Fidia farmaceutici S.p.A.
Fidia farmaceutici S.p.A. (Fidia) is a privately held pharmaceutical company targeting several therapeutic areas including Orthopaedics, traumatology, rheumatology and tissue repair, oncology and dermatology. The company principally offers hyaluronic acid products for intra-articular injection; and hyaluronic acid treatments used in tissue repair and over-the-counter products including dietary supplement. The company also provides a portfolio of generics to healthcare industry. The company offers its products in different forms such as tablets, capsules, sprays and creams. It is also in the research and development of new innovative formulations and technology include hyaluronic acid. The company is headquartered in Abano Terme, Italy.
In January 2010, Anika acquired Fidia Advanced Biopolymers. This acquisition will enable the company to develop its own direct US sales capability to capture higher margins from the domestic sales of Monovisc.